|
|
Effect of Buyang Huanwu Decoction combined with enhanced lipid-lowering anticoagulant in the treatment of ischemic stroke with syndrome of qi deficiency and blood stasis |
XU Lian |
Department of Traditional Chinese Medicine, Anhui Huaibei People′s Hospital, Anhui Province, Huaibei 235000, China |
|
|
Abstract Objective To explore the effect of Buyang Huanwu Decoction combined with enhanced lipid-lowering and anticoagulation in the treatment of ischemic stroke with syndrome of qi deficiency and blood stasis. Methods Two hundred patients of ischemic stroke with syndrome of qi deficiency and blood stasis admitted to Anhui Huaibei People′s Hospital from December 2015 to December 2019 were selected as research objects. Simple random number table method was used to divide the patients into two groups, with 100 cases in each group. Two groups were given antihypertensive, hypoglycemic, antiplatelet aggregation and other conventional treatment. Control group was treated with intensive lipid-lowering and anticoagulant therapy, and observation group was treated with Buyang Huanwu Decoction for two weeks. After treatment, the effect of two groups was compared. National Institute of Health stroke scale (NIHSS) score, traditional Chinese medicine syndrome score, serum nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) level and quality of life score of two groups were recorded before and after treatment. Results Total effective rate of observation group was significantly higher than that of control group, the difference was statistically significant (P < 0.05). NIHSS score and traditional Chinese medicine syndrome score of two groups after treatment were lower than those before treatment, and observation group was lower than control group, the differences were statistically significant (P < 0.05). The levels of NGF and BDNF in two groups after treatment were higher than those before treatment, and observation group was higher than control group, the differences were statistically significant (P < 0.05). The scores of health status, physiological function, emotional function and social function of two groups after treatment were higher than those before treatment, and observation group was higher than control group, the differences were statistically significant (P < 0.05). Conclusion Buyang Huanwu Decoction combined with enhanced lipid-lowering and anticoagulation can effectively alleviate clinical symptoms of patients, inhibit the expression levels of serum NGF and BDNF, and improve the quality of life, which can be widely used in clinic.
|
|
|
|
|
[1] 郑武.补阳还五汤治疗中风后遗症气虚血瘀证临床研究[J].中医学报,2017,32(12):2452-2455.
[2] 余长江,胡小军,訾璐,等.补阳还五汤加减配合针刺回阳九针穴联合康复训练治疗中风后遗症疗效研究[J].陕西中医,2019,40(7):861-863.
[3] Hayakawa M,Matsumaru Y,Yamagami H,et al. Trends in endovascular reperfusion therapy for acute stroke after introduction of mechanical thrombectomy devices:Japanese Registry of Neuroendovascular Therapy (JR-NET)3 [J]. Neurol Med Chir(Tokyo),2020,60(4):191-201.
[4] 王鸿波,张弘,陈伊,等.通督调神针法联合补阳还五汤对缺血性脑卒中恢复期(气虚血瘀)患者脑血流的影响[J].针灸临床杂志,2019,35(10):36-40.
[5] 何丹.补阳还五汤加减联合头针治疗缺血性中风失语气虚血瘀证的疗效研究[J].辽宁中医杂志,2017,44(7):1488-1491.
[6] 中华医学会神经病学分会中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[7] 张华.使用决策树从中医证候量表评分判断缺血性中风神经功能缺损程度[C]//2008中华中医药学会内科分会中医内科学科建设研讨会论文汇编,2008.
[8] 郭新峰,赖世隆.SF-36用于中国中风病人生存质量评价的信度、效度和可应用性[C]//2005全国中医脑病学术研讨会论文汇编,2005.
[9] 郑筱萸.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:99-104.
[10] Borghol A,Onor I,Neuliep A,et al. Effectiveness of mono antiplatelet therapy versus dual antiplatelet therapy in ischemic stroke or transient ischemic attack (TIa)-special subgroup consideration for the African-American population [J]. Int J Clin Pract,2020,9(12):e13504-e13506.
[11] 张业昊,姚明江,刘建勋.缺血性脑血管病的现代研究进展[J].中国药理学通报,2019,35(9):1185-1188.
[12] 张艳培,杨丹丹,周源,等.中医养阴活血法在缺血性中风疾病中的临床应用[J].中华中医药学刊,2019,37(12):3018-3020.
[13] 王爱丽,王倩.补阳还五汤联合丹红注射液对缺血性脑卒中气虚血瘀证神经功能及血清神经生长因子、脑源性神经细胞营养因子的影响[J].陕西中医,2019,40(6):692-695.
[14] 狄美琪,胡玲玲,孔亮,等.补阳还五汤对老年缺血性脑卒中病人临床疗效、神经功能评分及炎症因子水平的影响[J].实用老年医学,2019,33(4):386-388.
[15] Cho S,Kim J,Kim JB,et al. The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry) [J]. Sci Rep,2020,10(1):6319-6321.
[16] 李君玲,张秋梅,张江华.丹参粉针加补阳还五汤治疗气虚血瘀型缺血性脑中风疗效观察[J].河北中医药学报,2017,26(3):29.
[17] 邹文卫,蒋敏,赵颖,等.补阳还五汤煎剂联合西药治疗气虚血瘀证急性脑梗塞的临床研究[J].湖北中医药大学学报,2017,19(5):65-68.
[18] 石立鹏,杜旭勤,赵凤林,等.针刺联合补阳还五汤治疗气虚血瘀证冠心病稳定型心绞痛疗效及对血脂水平的影响[J].现代中西医结合杂志,2017,26(35):3880-3882,3966.
[19] Zerna C,Rogers E,Kamal N,et al. Comparative effectiveness of endovascular treatment for acute ischemic stroke:a population-based analysis [J]. J Am Heart Assoc,2020,9(7):e014541.
[20] 徐鹏,张冬梅,吕志国,等.补阳还五汤治疗缺血性中风恢复期疗效的系统评价[J].世界科学技术-中医药现代化,2018,20(11):1911-1923.
[21] 王成,项云霞,江桥.针灸联合加味补阳还五汤治疗PSD的疗效及对HAMD SDS BECK量表结果的影响[J].河北医学,2018,24(4):701-704.
[22] 姚德祎,陈星,卢云.中风醒脑液对缺血性脑中风早期神经功能恢复的影响[J].中国实验方剂学杂志,2020, 26(1):104-109.
[23] Matsubara N,Hiramatsu R,Miyachi S,et al. Other hospital-onset acute ischemic stroke due to large vessel occlusion treated by mechanical thrombectomy after inter-hospital transfer [J]. Neurol Med Chir (Tokyo),2020,60(4):209-216.
[24] 马玉兰,马青海,马骁.补阳还五汤合三七粉治疗缺血性中风恢复期气虚血瘀证的疗效观察[J].中药药理与临床,2016,32(5):93-96.
[25] 陈红霞,莫秀云,郭友华,等.补阳还五汤配合康复训练对气虚血瘀证脑梗死患者运动功能及日常生活活动能力恢复的效果评估[J].中国临床康复,2016,12(43):37-39.
[26] 路永坤,刘向哲,杨海燕,等.补阳还五汤加减方对气虚血瘀型脑梗死急性期血流灌注参数的影响[J].辽宁中医杂志,2019,16(10):14-18. |
|
|
|